Back to Search
GREGORY CALDWELL, DMD, MD
DMD, MD
Oral and Maxillofacial Surgery (Dentist)
NPI: 1992795926IndividualAccepts Medicare
Specialties, Licenses & Credentials
Oral and Maxillofacial Surgery (Dentist)Primary
Dentist — Oral and Maxillofacial Surgery
Code: 1223S0112X
19992(MA)
CMS Specialties
PrimaryORAL SURGERY
Education
TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE
Class of 1995
Research & Publications (20)
Screening for reactive intermediates and toxicity assessment in drug discovery.
PMID 16445117·Curr Opin Drug Discov Devel·2006
6-review
Distribution and metabolism of the antipsychotic agent mazapertine succinate in rats.
PMID 16386397·J Pharm Biomed Anal·2006
7-preclinical
Exposure to 2,4-decadienal negatively impacts upon marine invertebrate larval fitness.
PMID 15603766·Mar Environ Res·2005
7-preclinical
An animal model to discern torsin function: suppression of protein aggregation in C. elegans.
PMID 14509658·Adv Neurol·2004
4-observational
Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins.
PMID 12554684·Hum Mol Genet·2003
7-preclinical
The use of a brine shrimp (Artemia salina) bioassay to assess the toxicity of diatom extracts and short chain aldehydes.
PMID 14559082·Toxicon·2003
7-preclinical
Inhibition of embryonic development and fertilization in broadcast spawning marine invertebrates by water soluble diatom extracts and the diatom toxin 2-trans,4-trans decadienal.
PMID 12204592·Aquat Toxicol·2002
7-preclinical
Evaluation of the absorption, excretion and metabolism of [14C] etoperidone in man.
PMID 11765144·Xenobiotica·2001
8-other
The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery.
PMID 11899102·Curr Top Med Chem·2001
6-review
Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens.
PMID 19649835·Curr Opin Drug Discov Devel·2000
8-other
How strongly is muscle activity associated with joint moments?
PMID 10733292·Motor Control·2000
8-other
Muscle forces during running predicted by gradient-based and random search static optimisation algorithms.
PMID 18828028·Comput Methods Biomech Biomed Engin·2009
8-other
Scaling of plantarflexor muscle activity and postural time-to-contact in response to upper-body perturbations in young and older adults.
PMID 19504089·Exp Brain Res·2009
8-other
Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models.
PMID 19597508·Nat Chem Biol·2009
7-preclinical
The microtubule-associated protein, NUD-1, exhibits chaperone activity in vitro.
PMID 18626791·Cell Stress Chaperones·2009
7-preclinical
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity.
PMID 19182805·Nat Genet·2009
4-observational
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
PMID 19021916·Mol Brain·2008
7-preclinical
Generation of stable transgenic C. elegans using microinjection.
PMID 19066505·J Vis Exp·2008
7-preclinical
Paradigms for pharmacological characterization of C. elegans synaptic transmission mutants.
PMID 19066504·J Vis Exp·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 35 BEDFORD ST, SUITE 19
LEXINGTON, MA 02420 - Phone
- (781) 861-8855
Quick Facts
- NPI
- 1992795926
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile